Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 47

References for PMC Articles for PubMed (Select 21361360)

1.

Tumor pretargeting in mice using MORF conjugated CC49 antibody and radiolabeled complimentary cMORF effector.

Liu G, Dou S, Pretorius PH, Liu X, Chen L, Rusckowski M, Hnatowich DJ.

Q J Nucl Med Mol Imaging. 2010 Jun;54(3):333-40. Epub 2009 Dec 15.

2.

In vivo and in vitro characterization of [18F]-FE-(+)-DTBZ as a tracer for beta-cell mass.

Eriksson O, Jahan M, Johnström P, Korsgren O, Sundin A, Halldin C, Johansson L.

Nucl Med Biol. 2010 Apr;37(3):357-63. doi: 10.1016/j.nucmedbio.2009.12.004. Epub 2010 Jan 15.

PMID:
20346875
3.

Development of radiotracers for the determination of the beta-cell mass in vivo.

Brom M, Andrałojć K, Oyen WJ, Boerman OC, Gotthardt M.

Curr Pharm Des. 2010 May;16(14):1561-7. Review.

PMID:
20146667
4.

Towards high resolution optical imaging of beta cells in vivo.

Villiger M, Goulley J, Martin-Williams EJ, Grapin-Botton A, Lasser T.

Curr Pharm Des. 2010 May;16(14):1595-608. Review.

PMID:
20146662
5.

Generation of novel single-chain antibodies by phage-display technology to direct imaging agents highly selective to pancreatic beta- or alpha-cells in vivo.

Ueberberg S, Meier JJ, Waengler C, Schechinger W, Dietrich JW, Tannapfel A, Schmitz I, Schirrmacher R, Köller M, Klein HH, Schneider S.

Diabetes. 2009 Oct;58(10):2324-34. doi: 10.2337/db09-0658. Epub 2009 Jul 10.

6.

MRI as a tool to monitor islet transplantation.

Medarova Z, Moore A.

Nat Rev Endocrinol. 2009 Aug;5(8):444-52. doi: 10.1038/nrendo.2009.130. Epub 2009 Jun 23. Review.

PMID:
19546863
7.

Noninvasive imaging of pancreatic beta cells.

Malaisse WJ, Louchami K, Sener A.

Nat Rev Endocrinol. 2009 Jul;5(7):394-400. doi: 10.1038/nrendo.2009.103. Epub 2009 May 26. Review.

PMID:
19468290
8.

Isolation of major pancreatic cell types and long-term culture-initiating cells using novel human surface markers.

Dorrell C, Abraham SL, Lanxon-Cookson KM, Canaday PS, Streeter PR, Grompe M.

Stem Cell Res. 2008 Sep;1(3):183-94. doi: 10.1016/j.scr.2008.04.001. Epub 2008 May 8.

PMID:
19383399
9.

Replacing 99mTc with 111In improves MORF/cMORF pretargeting by reducing intestinal accumulation.

Liu G, Cheng D, Dou S, Chen X, Liang M, Pretorius PH, Rusckowski M, Hnatowich DJ.

Mol Imaging Biol. 2009 Sep-Oct;11(5):303-7. doi: 10.1007/s11307-009-0209-0. Epub 2009 Mar 27.

10.

Advances in beta-cell imaging.

Moore A.

Eur J Radiol. 2009 May;70(2):254-7. doi: 10.1016/j.ejrad.2009.01.044. Epub 2009 Mar 3. Review.

11.

11C-dihydrotetrabenazine PET of the pancreas in subjects with long-standing type 1 diabetes and in healthy controls.

Goland R, Freeby M, Parsey R, Saisho Y, Kumar D, Simpson N, Hirsch J, Prince M, Maffei A, Mann JJ, Butler PC, Van Heertum R, Leibel RL, Ichise M, Harris PE.

J Nucl Med. 2009 Mar;50(3):382-9. doi: 10.2967/jnumed.108.054866. Epub 2009 Feb 17. Erratum in: J Nucl Med. 2009 Oct;50(10):1578.

12.

Noninvasive assessment of pancreatic beta-cell function in vivo with manganese-enhanced magnetic resonance imaging.

Antkowiak PF, Tersey SA, Carter JD, Vandsburger MH, Nadler JL, Epstein FH, Mirmira RG.

Am J Physiol Endocrinol Metab. 2009 Mar;296(3):E573-8. doi: 10.1152/ajpendo.90336.2008. Epub 2008 Dec 30.

13.

Relationship between pancreatic vesicular monoamine transporter 2 (VMAT2) and insulin expression in human pancreas.

Saisho Y, Harris PE, Butler AE, Galasso R, Gurlo T, Rizza RA, Butler PC.

J Mol Histol. 2008 Oct;39(5):543-51. doi: 10.1007/s10735-008-9195-9. Epub 2008 Sep 13.

14.

A new immunodeficient hyperglycaemic mouse model based on the Ins2Akita mutation for analyses of human islet and beta stem and progenitor cell function.

Pearson T, Shultz LD, Lief J, Burzenski L, Gott B, Chase T, Foreman O, Rossini AA, Bottino R, Trucco M, Greiner DL.

Diabetologia. 2008 Aug;51(8):1449-56. doi: 10.1007/s00125-008-1057-1. Epub 2008 Jun 19.

15.

In vivo imaging of beta-cell mass in rats using 18F-FP-(+)-DTBZ: a potential PET ligand for studying diabetes mellitus.

Kung MP, Hou C, Lieberman BP, Oya S, Ponde DE, Blankemeyer E, Skovronsky D, Kilbourn MR, Kung HF.

J Nucl Med. 2008 Jul;49(7):1171-6. doi: 10.2967/jnumed.108.051680. Epub 2008 Jun 13.

16.

Imaging the Beta-cell mass: why and how.

Saudek F, Brogren CH, Manohar S.

Rev Diabet Stud. 2008 Spring;5(1):6-12. doi: 10.1900/RDS.2008.5.6. Epub 2008 May 10.

17.

Creation of "humanized" mice to study human immunity.

Pearson T, Greiner DL, Shultz LD.

Curr Protoc Immunol. 2008 May;Chapter 15:Unit 15.21. doi: 10.1002/0471142735.im1521s81.

18.

Real-time imaging of the pancreas during development of diabetes.

Martinic MM, von Herrath MG.

Immunol Rev. 2008 Feb;221:200-13. doi: 10.1111/j.1600-065X.2008.00581.x. Review.

PMID:
18275484
19.

A new Hu-PBL model for the study of human islet alloreactivity based on NOD-scid mice bearing a targeted mutation in the IL-2 receptor gamma chain gene.

King M, Pearson T, Shultz LD, Leif J, Bottino R, Trucco M, Atkinson MA, Wasserfall C, Herold KC, Woodland RT, Schmidt MR, Woda BA, Thompson MJ, Rossini AA, Greiner DL.

Clin Immunol. 2008 Mar;126(3):303-14. Epub 2007 Dec 21.

PMID:
18096436
20.

Pretargeting CWR22 prostate tumor in mice with MORF-B72.3 antibody and radiolabeled cMORF.

Liu G, Dou S, Pretorius PH, Liu X, Rusckowski M, Hnatowich DJ.

Eur J Nucl Med Mol Imaging. 2008 Feb;35(2):272-80. Epub 2007 Oct 2.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk